- post by: Corey
- December 03, 2016
Genetic test could ‘hugely improve’ prognosis for esophageal cancer
Genetic test could ‘hugely improve’ prognosis for esophageal cancer
Researchers have pinpointed the genetic basis of why some people with a serious
complication of acid reflux known as Barrett’s esophagus go on to develop esophageal cancer. They
believe their discovery, along with a novel non-invasive test, means esophageal cancer could be
detected much earlier, thereby improving the prognosis of what is currently a cancer with a poor
Writing in the journal Nature Genetics, the large international team, including
scientists from the University of Southampton in the UK, describe how they found mutations in two
genes mark the progression from Barrett’s esophagus to esophageal cancer.
They also describe how a new non-invasive tool that uses a “sponge-on-a-string” is capable of
retrieving cells from the esophagus that can then be tested for mutations in the two genes.
Such a test has the potential to completely change the game for diagnosing esophageal cancer
much earlier than at present.
Esophageal cancer has a poor survival rate
According to the American Cancer Society, esophageal cancer makes up about 1% of all cancers
diagnosed in the US, where estimates suggest in 2014, about 18,170 people will discover
they have the cancer, and about 15,450 will die of it.
Although survival rates for esophageal cancer have improved since the 1960s and 1970s, when
only 5% of patients survived at least 5 years after diagnosis, today that figure is still only
about 20%. Survival rates for people with early stage cancer are higher.
There are two types of esophageal cancer: adenocarcinoma and squamous cell carcinoma. People
with Barrett’s esophagus – a condition that can develop from prolonged, untreated acid reflux or
heartburn – have a higher risk of developing adenocarcinoma of the esophagus.
Unfortunately, Barrett’s esophagus often goes undiagnosed, making it difficult to spot people
who are at higher risk of developing esophageal cancer.
Mutations in two genes may mark Barrett’s esophagus progressing to cancer
In this new study, the team sequenced the DNA of patients with Barrett’s esophagus and patients
with esophageal cancer, and mapped out their genetic similarities and differences.
The team sequenced the DNA of patients with Barrett’s esophagus and patients with esophageal cancer, and mapped out their genetic similarities and differences.
They found mutations in the genes TP53 and SMAD4 offered a way of identifying patients in which
Barrett’s esophagus is progressing into cancer.
Another feature of the study was the use of a “non-endoscopic” test to identify high-risk
Barrett’s esophagus by retrieving cells from the affected part of the esophagus that could then be
checked for presence of the mutated genes.
The “non-endoscopic” test is the cytosponge, or “sponge-on-a-string” test, and involves the
patient swallowing a capsule containing a sponge attached to a thread. When the capsule reaches
the stomach it dissolves, releasing the sponge, which collects cells from the esophagus wall as it
is pulled out by the clinician or nurse.
The cytosponge is still under development, but the researchers believe it could be used to look
for mutations in TP53 and SMAD4 to identify patients with early stage esophageal cancer.
In collaboration with University Hospital Southampton NHS Foundation Trust, the University of
Southampton provided the researchers with the second largest amount of samples.
Co-author Tim Underwood, a Medical Research Council (MRC) Clinician Scientist at the
University, and esophageal surgeon at the Hospital, led the Southampton team. He says:
“This is a landmark study into the genetic basis of why and how some people with Barrett’s
esophagus get esophageal cancer and others do not. It is still early, but we very much hope that
this information will lead to a game-changer for a cancer with one of the worst outcomes.”
He says the findings also suggest “we may need to look outside the cancer itself to find the
next generation of treatments.” He explains Southampton is already leading follow-on research that
focuses on “disrupting the interaction between cancer cells and normal cells around the tumor that
appear to support cancer growth.”
Researchers hope sponge-on-a-string test may soon be in hospitals
Co-author Rebecca Fitzgerald, a professor based at the MRC Cancer Unit at the University of
Cambridge in the UK, says:
“We developed the sponge-on-a-string test as an easy way of getting a sample of the cells that
line the esophagus. When combined with powerful gene sequencing technology, this will help us to
quickly identify which patients have Barrett’s and which have started to develop esophageal
cancer, and we hope the test will soon be routinely available in hospitals.”
Nell Barrie, head of science information at Cancer Research UK, who were involved with funding
for the study, says, “The Cytosponge test could be a simple and cheap way to help diagnose the
disease earlier, when there’s a greater chance treatment will be effective.”
She also urges anyone who keeps having problems with food getting stuck when they swallow and
persistent heartburn to see their doctor: “It probably won’t be cancer, but it’s essential to get
checked out,” she says.
The study was funded by The Catalyst Club, which is organized by Cancer Research UK and is made up
of philanthropists who have invested in a range of projects that aim to bring forward the day when
all cancers are cured.
Meanwhile, Medical News Today recently reported how researchers discovered a promising biomarker for esophageal
cancer. Presenting the results of their study at Digestive Disease Week in Chicago in May, the
team said the new biomarker showed promise in improving screening for esophageal cancer and
What’s molluscum contagiosum? What can cause molluscum contagiosum? Molluscum contagiosum is really a contagious skin infection brought on by the molluscum contagiosum virus (MCV) that triggers elevated, gem-like nodules or papules onto the skin – these growths are known as molluscum physiques, mollusca or condyloma subcutaneum. Herpes is one of the family known as […]
‘Beauty rest’ aftereffect of CPAP anti snoring treatment Obtaining a sound night of sleep can improve our overall health in lots of ways. And today, new research printed within the Journal of Clinical Sleep Prescription medication is the very first available to evaluate how patients appear more alert, youthful and engaging after undergoing anti […]
Cleft lip and cleft palate Cleft lip and cleft palate are hereditary deformities from the face which happen before an infant comes into the world. A cleft can be very visible, and it can result in medical, behavior, and social difficulties, but nowadays, it’s routinely remedied by surgery. Before birth, natural structures form in […]
Digital mammography might help predict cardiovascular disease Mammography may help predict cardiovascular disease in females by discovering indications of calcium within the arterial blood vessels from the breast. This might make early treatment possible, with potential benefits, specifically for youthful women. Ladies who have calcifications within the breast arterial blood vessels will probably have […]
Propecia (finasteride) Permanent Sexual Disorder Risk Hair thinning medication, Propecia (finasteride) might be associated with an unwanted effect of sexual disorder, an issue which might not disappear after treatment has stopped, researchers from George Washington College reported within the Journal of Sexual Medicine. Propecia is a well-liked medication taken for male pattern baldness. Michael S. […]